RNXT

RenovoRx (RNXT)

RenovoRx Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RNXT

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/08	22 : 00	Business Wire	RenovoRx Announces Acceptance of Abstract for Presentation at ASCO Gastrointestinal Cancers Symposium 2025	NASDAQ:RNXT	RenovoRx Inc
2024/12/30	22 : 00	Business Wire	RenovoRx Continues to Grow Intellectual Property Portfolio for its Novel Drug-Delivery Therapy Platform	NASDAQ:RNXT	RenovoRx Inc
2024/12/11	22 : 00	GlobeNewswire Inc.	RenovoRx Initiates Patient Enrollment at SCRI Oncology Partners for Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic Cancer	NASDAQ:RNXT	RenovoRx Inc
2024/12/10	22 : 00	GlobeNewswire Inc.	RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ET	NASDAQ:RNXT	RenovoRx Inc
2024/12/05	22 : 00	GlobeNewswire Inc.	RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System	NASDAQ:RNXT	RenovoRx Inc
2024/11/20	22 : 45	GlobeNewswire Inc.	Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial	NASDAQ:RNXT	RenovoRx Inc
2024/11/14	22 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNXT	RenovoRx Inc
2024/11/14	22 : 00	GlobeNewswire Inc.	RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights	NASDAQ:RNXT	RenovoRx Inc
2024/11/14	06 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RNXT	RenovoRx Inc
2024/10/03	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc
2024/10/03	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc
2024/09/26	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNXT	RenovoRx Inc
2024/09/25	21 : 30	GlobeNewswire Inc.	RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians	NASDAQ:RNXT	RenovoRx Inc
2024/09/19	21 : 30	GlobeNewswire Inc.	RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer	NASDAQ:RNXT	RenovoRx Inc
2024/08/27	21 : 30	GlobeNewswire Inc.	RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York	NASDAQ:RNXT	RenovoRx Inc
2024/08/17	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNXT	RenovoRx Inc
2024/08/14	21 : 30	GlobeNewswire Inc.	RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial	NASDAQ:RNXT	RenovoRx Inc
2024/08/14	06 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RNXT	RenovoRx Inc
2024/07/31	21 : 30	GlobeNewswire Inc.	RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist®	NASDAQ:RNXT	RenovoRx Inc
2024/07/08	21 : 30	GlobeNewswire Inc.	RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®	NASDAQ:RNXT	RenovoRx Inc
2024/06/26	21 : 30	GlobeNewswire Inc.	University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial	NASDAQ:RNXT	RenovoRx Inc
2024/06/10	21 : 30	GlobeNewswire Inc.	RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships	NASDAQ:RNXT	RenovoRx Inc
2024/06/08	05 : 41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNXT	RenovoRx Inc
2024/05/30	21 : 30	Business Wire	RenovoRx CEO Issues Update Letter to Shareholders	NASDAQ:RNXT	RenovoRx Inc
2024/05/21	22 : 00	Business Wire	Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery	NASDAQ:RNXT	RenovoRx Inc
2024/05/14	22 : 00	Business Wire	RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024	NASDAQ:RNXT	RenovoRx Inc
2024/05/13	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:RNXT	RenovoRx Inc
2024/05/13	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:RNXT	RenovoRx Inc
2024/05/11	06 : 21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RNXT	RenovoRx Inc
2024/05/11	05 : 50	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:RNXT	RenovoRx Inc